• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘结局研讨会:概述。

Asthma outcomes workshop: overview.

机构信息

University of Wisconsin, Madison, Wisconsin, USA.

出版信息

J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S1-8. doi: 10.1016/j.jaci.2011.12.985.

DOI:10.1016/j.jaci.2011.12.985
PMID:22386504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4259286/
Abstract

BACKGROUND

Asthma clinical research will highly benefit from standardization of major outcomes in terms of definition and assessment methodology. This will permit useful comparisons across interventional or observational studies and will allow more effective data sharing.

OBJECTIVE

National Institutes of Health (NIH) institutes and the Agency for Healthcare Research and Quality convened a workshop involving 7 expert subcommittees to propose which asthma outcomes should be assessed with standardized methodology in future asthma clinical research studies.

METHODS

Each subcommittee utilized comprehensive literature reviews and expert opinion to compile a list of asthma outcomes and classified them as either core (required in future studies), supplemental (to be used according to study aims and standardized), or emerging (requiring validation and standardization). This work was discussed at an NIH-organized workshop in March 2010 and finalized in September 2011.

RESULTS

Outcomes for study participant characterization, as well as for prospective clinical trial intervention and observational studies, were proposed for adults and children, and methodologies for outcome collection and reporting were determined. Furthermore, the workshop identified areas in which new outcomes or instruments for their measurement need to be developed and validated.

CONCLUSIONS

Standardized outcomes for clinical research in asthma have been proposed. Participating NIH institutes and other federal agencies will consider these recommendations in future clinical research initiatives in asthma.

摘要

背景

哮喘临床研究将从主要结局的定义和评估方法的标准化中受益匪浅。这将允许在干预性或观察性研究之间进行有用的比较,并允许更有效的数据共享。

目的

美国国立卫生研究院(NIH)研究所和医疗保健研究与质量局召集了一个研讨会,涉及 7 个专家小组委员会,提出在未来的哮喘临床研究中应使用标准化方法评估哪些哮喘结局。

方法

每个小组委员会利用全面的文献回顾和专家意见,编制了一份哮喘结局清单,并将其分为核心(未来研究中必需的)、补充(根据研究目的和标准化使用)或新兴(需要验证和标准化)。这项工作在 2010 年 3 月由 NIH 组织的研讨会上进行了讨论,并在 2011 年 9 月最终确定。

结果

为研究参与者特征、前瞻性临床试验干预和观察性研究提出了成人和儿童的研究结果,并确定了结果收集和报告的方法。此外,研讨会确定了需要开发和验证新的结果或测量工具的领域。

结论

已经提出了哮喘临床研究的标准化结局。参与 NIH 研究所和其他联邦机构将在未来的哮喘临床研究计划中考虑这些建议。

相似文献

1
Asthma outcomes workshop: overview.哮喘结局研讨会:概述。
J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S1-8. doi: 10.1016/j.jaci.2011.12.985.
2
Asthma outcomes: pulmonary physiology.哮喘结局:肺生理学。
J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S65-87. doi: 10.1016/j.jaci.2011.12.986.
3
Asthma outcomes: symptoms.哮喘结局:症状。
J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S124-35. doi: 10.1016/j.jaci.2011.12.981.
4
Asthma outcomes: healthcare utilization and costs.哮喘结局:医疗保健利用和成本。
J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S49-64. doi: 10.1016/j.jaci.2011.12.984.
5
Asthma outcomes: composite scores of asthma control.哮喘结局:哮喘控制的综合评分。
J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S24-33. doi: 10.1016/j.jaci.2011.12.980.
6
Asthma outcomes: exacerbations.哮喘结局:恶化。
J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S34-48. doi: 10.1016/j.jaci.2011.12.983.
7
Asthma outcomes: biomarkers.哮喘结局:生物标志物。
J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S9-23. doi: 10.1016/j.jaci.2011.12.979.
8
Asthma outcomes: quality of life.哮喘结局:生活质量。
J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S88-123. doi: 10.1016/j.jaci.2011.12.988.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Mediators of asthma outcomes.哮喘结局的介质。
J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S136-41. doi: 10.1016/j.jaci.2011.12.987.

引用本文的文献

1
Association of delayed asthma diagnosis with asthma exacerbations in children.儿童哮喘延迟诊断与哮喘急性加重的关联。
J Allergy Clin Immunol Glob. 2025 Jan 16;4(2):100409. doi: 10.1016/j.jacig.2025.100409. eCollection 2025 May.
2
Ratio of plasma IL-13/TNF- ∝ and CXCL10/CCL17 predicts mepolizumab and omalizumab response in asthma better than eosinophil count or immunoglobulin E level.血浆 IL-13/TNF-∝和 CXCL10/CCL17 的比值比嗜酸性粒细胞计数或免疫球蛋白 E 水平更能预测美泊利单抗和奥马珠单抗治疗哮喘的反应。
Sci Rep. 2024 May 6;14(1):10404. doi: 10.1038/s41598-024-60864-3.
3
Managing children's asthma: what role do caregivers' mental representations of trigger and symptom management behaviors play?管理儿童哮喘:照顾者对触发因素及症状管理行为的心理表征起到了什么作用?
Psychol Health. 2024 Apr 29:1-21. doi: 10.1080/08870446.2024.2347657.
4
Lower myostatin and higher MUC1 levels are associated with better response to mepolizumab and omalizumab in asthma: a protein-protein interaction analyses.较低的肌肉生长抑制素和较高的 MUC1 水平与对美泊利珠单抗和奥马珠单抗治疗哮喘的更好反应相关:蛋白质-蛋白质相互作用分析。
Respir Res. 2023 Dec 6;24(1):305. doi: 10.1186/s12931-023-02620-1.
5
How are mental representations of asthma triggers and symptoms related to interpersonal risk perceptions? A psychometric investigation of caregivers of children with asthma.哮喘触发因素和症状的心理表征与人际风险认知有何关联?一项针对哮喘患儿照料者的心理测量学调查。
Psychol Health. 2025 Apr;40(4):571-593. doi: 10.1080/08870446.2023.2244522. Epub 2023 Aug 6.
6
A Charter to Fundamentally Change the Role of Oral Corticosteroids in the Management of Asthma.《改变哮喘管理中口服皮质类固醇作用的宪章》
Adv Ther. 2023 Jun;40(6):2577-2594. doi: 10.1007/s12325-023-02479-0. Epub 2023 Apr 7.
7
Artificial intelligence based software facilitates spirometry quality control in asthma and COPD clinical trials.基于人工智能的软件有助于哮喘和慢性阻塞性肺疾病临床试验中的肺活量测定质量控制。
ERJ Open Res. 2023 Jan 3;9(1). doi: 10.1183/23120541.00292-2022. eCollection 2023 Jan.
8
An asthma collaboration to reduce childhood asthma disparities on the Navajo Nation: Trial protocol for the Community Asthma Program.一项旨在减少纳瓦霍族儿童哮喘差异的哮喘合作项目:社区哮喘计划试验方案
Public Health Pract (Oxf). 2022 Jul 21;4:100289. doi: 10.1016/j.puhip.2022.100289. eCollection 2022 Dec.
9
Respiratory pathogens and clinical outcomes in children with an asthma exacerbation: A systematic review.哮喘急性加重患儿的呼吸道病原体与临床结局:一项系统评价
J Assoc Med Microbiol Infect Dis Can. 2019 Oct 11;4(3):145-168. doi: 10.3138/jammi.2019-0004. eCollection 2019 Oct.
10
Level of asthma control and its determinants among adults living with asthma attending selected public hospitals in northwestern, Ethiopia: using an ordinal logistic regression model.埃塞俄比亚西北部部分公立医院成年哮喘患者的哮喘控制水平及其决定因素:采用有序逻辑回归模型
Asthma Res Pract. 2022 Aug 27;8(1):5. doi: 10.1186/s40733-022-00087-3.

本文引用的文献

1
Asthma prevalence, health care use, and mortality: United States, 2005-2009.2005 - 2009年美国哮喘患病率、医疗保健利用情况及死亡率
Natl Health Stat Report. 2011 Jan 12(32):1-14.
2
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.美国胸科学会/欧洲呼吸学会官方声明:哮喘控制与加重:规范临床哮喘试验及临床实践的终点指标
Am J Respir Crit Care Med. 2009 Jul 1;180(1):59-99. doi: 10.1164/rccm.200801-060ST.